Project Grant R00AR083536
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant totaling $224,100 to the Regents of the University of California at Riverside, effective September 15, 2025, with a completion date of August 31, 2028. Under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), this award supports scientific research investigating epigenetic factors that control epidermal stem cell longevity...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded University of California, Davis a Project Grant totaling $169,344.00 under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) effective July 15, 2025, with completion targeted for June 30, 2030. This research project delivers mechanistic investigation into fracture healing complications in polytrauma patients, addressing a critical clinical gap...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a Project Grant of $150,152 to the University of California, Los Angeles (UCLA) on March 27, 2026, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports a three-year research initiative through February 28, 2029, focused on characterizing migratory cell differentiation in developing zebrafish skin. The research will elucidate...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Wisconsin System a $902,444 Project Grant on February 27, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to develop and validate nanogenerator-driven electrostimulation (NG-ES) technology for accelerated wound healing. The research aims to establish a comprehensive cellular and tissue-level understanding of how...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded $170,316 to the University of California, Davis on August 10, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to support a four-year research career development initiative addressing trauma-induced heterotopic ossification (THO). The project, scheduled for completion by July 31, 2029, focuses on investigating nociception-induced...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded the University of Miami a $3.65 million Project Grant (CFDA 93.846: Arthritis, Musculoskeletal and Skin Diseases Research) effective September 1, 2025, through August 31, 2028. This research project delivers scientific investigation into the role of Langerhans cells (LCs) in chronic itch conditions, addressing a significant gap in understanding how epidermal resident...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $1.87 million Project Grant to The Johns Hopkins University on May 12, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research project, titled "Inhibition of Regeneration Restraining Pathways to Promote Healing," will be conducted in Baltimore, Maryland, with a completion date of February 28, 2030. This research...
- Federal Project Grant Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Washington University a five-year training and research project grant totaling $258,070 (awarded September 26, 2025; completion date August 31, 2030) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports an integrated mentored training program and research initiative designed to develop an academic physician-scientist...
- Federal Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Leland Stanford Junior University a Project Grant of $102,341 on September 10, 2025, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This research initiative, scheduled for completion by June 30, 2027, focuses on characterizing RNA-dependent protein assemblies and their role in epidermal homeostasis. The project addresses the significant...
- Federal Project Grant Award Summary The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $249,000 project grant to the University of Massachusetts Medical School (effective July 1, 2025 through June 30, 2028) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds the development of a programmable small interfering RNA (siRNA)-based therapeutic platform for gene silencing in skin diseases. The research focuses...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $249,000 Project Grant to the University of California, Irvine, effective February 1, 2026 through January 31, 2029, under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). This award funds research to decode the repair and immunomodulatory functions of lymphatic vessels in wound healing, with the objective of advancing understanding of mechanisms underlying lymphatic vessel remodeling during skin repair and determining the role of lymphatic vessels and fluid pressure in macrophage behavior. The research aims to establish foundational knowledge that can inform development of new therapeutic interventions for lymphedema ulcers and chronic wound management. The funded research project will deliver scientific investigation and analysis focused on elucidating how lymphatic vessel dysfunction contributes to impaired wound healing and identifying therapeutic targets for chronic wound conditions. The work includes characterization of lymphatic vessel remodeling mechanisms, assessment of immune cell infiltration patterns during repair, and investigation of fluid pressure dynamics in macrophage function. Deliverables from this three-year project are expected to generate peer-reviewed scientific findings and establish evidence-based approaches for developing clinical interventions in lymphedema and chronic wound management.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $249.0k | 2/5/26 |